ACVR2A and hepatocellular carcinoma: These data suggest that our syngeneic mouse model is a valuable tool for basic research on biological and molecular mechanisms and preclinical evaluation of therapeutic strategies for ACVR2A-deficient and Treg cell-rich HCC.